- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 5.49M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.09M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $45.58M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $15.12M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $18.62M |
| Current Assets | FY 2024 · Dec 31, 2023 | $4.2M |
| Total Assets | FY 2024 · Dec 31, 2023 | $67.63M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 222.41K sh |
| Capex | FY 2024 · Dec 31, 2022 | $59K |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$2.39M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | −$380.86 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | −$380.86 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $46.49M |
| Net Income | FY 2024 · Dec 31, 2022 | −$84.71M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$47.94M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $646K |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $82.19M |
| Revenue | FY 2024 · Dec 31, 2022 | $82.84M |